NO963131L - Endotelinreseptorantagonister - Google Patents

Endotelinreseptorantagonister

Info

Publication number
NO963131L
NO963131L NO963131A NO963131A NO963131L NO 963131 L NO963131 L NO 963131L NO 963131 A NO963131 A NO 963131A NO 963131 A NO963131 A NO 963131A NO 963131 L NO963131 L NO 963131L
Authority
NO
Norway
Prior art keywords
unsubstituted
nhsor
hal
phenyl
rsubstituted
Prior art date
Application number
NO963131A
Other languages
English (en)
Norwegian (no)
Other versions
NO963131D0 (no
Inventor
Mathias Osswald
Dieter Dorsch
Werner Mederski
Claudia Wilm
Claus J Schmitges
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963131D0 publication Critical patent/NO963131D0/no
Publication of NO963131L publication Critical patent/NO963131L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO963131A 1995-07-28 1996-07-26 Endotelinreseptorantagonister NO963131L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19527568A DE19527568A1 (de) 1995-07-28 1995-07-28 Endothelin-Rezeptor-Antagonisten

Publications (2)

Publication Number Publication Date
NO963131D0 NO963131D0 (no) 1996-07-26
NO963131L true NO963131L (no) 1997-01-29

Family

ID=7767990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963131A NO963131L (no) 1995-07-28 1996-07-26 Endotelinreseptorantagonister

Country Status (16)

Country Link
US (1) US5700807A (fr)
EP (1) EP0755934A1 (fr)
JP (1) JPH0940678A (fr)
KR (1) KR970006305A (fr)
AU (1) AU6060796A (fr)
BR (1) BR9603164A (fr)
CA (1) CA2182156A1 (fr)
CZ (1) CZ219796A3 (fr)
DE (1) DE19527568A1 (fr)
HU (1) HUP9602054A3 (fr)
MX (1) MX9603045A (fr)
NO (1) NO963131L (fr)
PL (1) PL315422A1 (fr)
SK (1) SK92496A3 (fr)
TW (1) TW367328B (fr)
ZA (1) ZA966399B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291442B1 (en) 1998-02-03 2001-09-18 The General Hospital Corporation Pharmacological modulators of voltage-gated potassium ion channels
IL125659A (en) † 1998-08-05 2002-09-12 Cadent Ltd Method and device for three-dimensional simulation of a structure
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
EP1465869B1 (fr) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulateurs de lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1487813B1 (fr) * 2002-02-22 2006-08-30 Bayer Pharmaceuticals Corporation Derives de benzofurane et de benzothiophene utilises dans le traitement de troubles hyperproliferatifs
NZ545805A (en) * 2003-08-29 2009-12-24 Ono Pharmaceutical Co Compound capable of binding S1P receptor and pharmaceutical use thereof
WO2015088564A1 (fr) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. Composés modulateurs du récepteur p2x4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339959A3 (fr) * 1988-04-27 1991-03-20 Glaxo Group Limited Dérivés de lactame
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
RU2125980C1 (ru) 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
ZA939516B (en) 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DE69422742T2 (de) 1993-03-19 2000-08-17 Merck & Co Inc Phenoxyphenylessigsäurederivate
EP0763035A4 (fr) * 1994-06-09 1997-10-01 Smithkline Beecham Corp Antagonistes du recepteur de l'endotheline

Also Published As

Publication number Publication date
MX9603045A (es) 1997-01-31
ZA966399B (en) 1997-02-19
PL315422A1 (en) 1997-02-03
HUP9602054A2 (en) 1997-11-28
EP0755934A1 (fr) 1997-01-29
HUP9602054A3 (en) 1998-07-28
AU6060796A (en) 1997-02-06
KR970006305A (ko) 1997-02-19
JPH0940678A (ja) 1997-02-10
CZ219796A3 (en) 1997-02-12
NO963131D0 (no) 1996-07-26
HU9602054D0 (en) 1996-09-30
US5700807A (en) 1997-12-23
BR9603164A (pt) 1998-05-05
TW367328B (en) 1999-08-21
CA2182156A1 (fr) 1997-01-29
DE19527568A1 (de) 1997-01-30
SK92496A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
DK0590428T3 (da) Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse
FI913503A (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI901739A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
SE8700535L (sv) Dikloranilinderivat
DK0530505T3 (da) Hydantoinderivater
DE59209742D1 (de) N-Acyl-S-(2-hydroxyalkyl)-cysteine, deren Herstellung sowie deren Verwendung als Zwischenprodukte zur Herstellung von synthetischen Immunadjuvantien und synthetischen Impfstoffen
NO963131L (no) Endotelinreseptorantagonister
SE8503466D0 (sv) Aminofenolforeningar
NO953052L (no) Nye pyrrolokarbazoler
FI930236A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
CO5150201A1 (es) Derivados de piperidina
NO911004L (no) (benzhydryloksyetylpiperidyl)alifatiske syrederivater og anvendelse derav.
AU5528986A (en) Novel (4.2.0)bicyclooctane derivatives with valuable therapeutic properties
YU166291A (sh) Indenoindol jedinjenja
ATE154010T1 (de) 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften
FI941650A (fi) Uudet fluorikinolin-3-karboksyylihappojohdannaiset ja niiden valmistus
EP0278728A3 (fr) Dérivés de 1-(4-amino-3,5-dichlorophényl)-2-(amino substitué)éthanol et leur utilisation pour le traitement des maladies respiratoires
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
FI833553A (fi) Foerfarande foer framstaellning av nya imidazo/1,2-a/kinoliner och deras salter
MY101756A (en) Dichloroaniline derivatives
TW257759B (en) Piperazine derivatives (2)